
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
San Francisco - Making laser surgery as pleasant an experience as possible is important when the patient is a child because optimal clearing of many common pediatric lesions treated with a laser involves multiple sessions, Heidi A. Waldorf, M.D., said at the annual meeting of the American Academy of Dermatology.






